(Press-News.org) NGC 6559 is a cloud of gas and dust located at a distance of about 5000 light-years from Earth, in the constellation of Sagittarius (The Archer). The glowing region is a relatively small object, just a few light-years across, in contrast to the one hundred light-years and more spanned by its famous neighbour, the Lagoon Nebula (Messier 8, eso0936 - http://www.eso.org/public/news/eso0936/). Although it is usually overlooked in favour of its distinguished companion, NGC 6559 has the leading role in this new picture.
The gas in the clouds of NGC 6559, mainly hydrogen, is the raw material for star formation. When a region inside this nebula gathers enough matter, it starts to collapse under its own gravity. The centre of the cloud grows ever denser and hotter, until thermonuclear fusion begins and a star is born. The hydrogen atoms combine to form helium atoms, releasing energy that makes the star shine.
These brilliant hot young stars born out of the cloud energise the hydrogen gas still present around them in the nebula [1]. The gas then re-emits this energy, producing the glowing threadlike red cloud seen near the centre of the image. This object is known as an emission nebula.
But NGC 6559 is not just made out of hydrogen gas. It also contains solid particles of dust, made of heavier elements, such as carbon, iron or silicon. The bluish patch next to the red emission nebula shows the light from the recently formed stars being scattered -- reflected in many different directions -- by the microscopic particles in the nebula. Known to astronomers as a reflection nebula, this type of object usually appears blue because the scattering is more efficient for these shorter wavelengths of light [2].
In regions where it is very dense, the dust completely blocks the light behind it, as is the case for the dark isolated patches and sinuous lanes to the bottom left-hand side and right-hand side of the image. To look through the clouds at what lies behind, astronomers would need to observe the nebula using longer wavelengths that would not be absorbed.
The Milky Way fills the background of the image with countless yellowish older stars. Some of them appear fainter and redder because of the dust in NGC 6559.
This eye-catching image of star formation was captured by the Danish Faint Object Spectrograph and Camera (DFOSC) on the 1.54-metre Danish Telescope at La Silla in Chile. This national telescope has been in use at La Silla since 1979 and was recently refurbished to turn it into a remote-controlled state-of-the-art telescope.
INFORMATION:
Notes
[1] These young stars are usually of spectral type O and B, with temperatures between 10 000 and 60 000 K, which radiate huge amounts of high energy ultraviolet light that ionises the hydrogen atoms.
[2] Rayleigh scattering, named after the British physicist Lord Rayleigh, happens when light is scattered off particles of material that are much smaller than the wavelength of the light. It is much more effective for short wavelengths of light, that is, wavelengths corresponding to the blue end of the visible spectrum, so the result is a bluish diffuse light. This is the same mechanism that explains the blue colour of the daytime cloud-free sky.
More information
ESO is the foremost intergovernmental astronomy organisation in Europe and the world's most productive ground-based astronomical observatory by far. It is supported by 15 countries: Austria, Belgium, Brazil, the Czech Republic, Denmark, France, Finland, Germany, Italy, the Netherlands, Portugal, Spain, Sweden, Switzerland and the United Kingdom. ESO carries out an ambitious programme focused on the design, construction and operation of powerful ground-based observing facilities enabling astronomers to make important scientific discoveries. ESO also plays a leading role in promoting and organising cooperation in astronomical research. ESO operates three unique world-class observing sites in Chile: La Silla, Paranal and Chajnantor. At Paranal, ESO operates the Very Large Telescope, the world's most advanced visible-light astronomical observatory and two survey telescopes. VISTA works in the infrared and is the world's largest survey telescope and the VLT Survey Telescope is the largest telescope designed to exclusively survey the skies in visible light. ESO is the European partner of a revolutionary astronomical telescope ALMA, the largest astronomical project in existence. ESO is currently planning the 39-metre European Extremely Large optical/near-infrared Telescope, the E-ELT, which will become "the world's biggest eye on the sky".
Links
Photos of the Danish telescope - http://www.eso.org/public/images/archive/search/?adv=&subject_name=1.54
Photos taken with the Danish telescope - http://www.eso.org/public/images/archive/search/?adv=&facility=18
ESO press releases with results from the Danish telescope - http://www.eso.org/public/news/archive/search/?adv=&facility=18
Contacts
Richard Hook
ESO Public Information Officer
Garching bei München, Germany
Cell: +49 151 1537 3591
An anarchic region of star formation
2013-05-02
ELSE PRESS RELEASES FROM THIS DATE:
Adult cells transformed into early-stage nerve cells, bypassing the pluripotent stem cell stage
2013-05-02
MADISON, Wis. — A University of Wisconsin-Madison research group has converted skin cells from people and monkeys into a cell that can form a wide variety of nervous-system cells — without passing through the do-it-all stage called the induced pluripotent stem cell, or iPSC.
Bypassing the ultra-flexible iPSC stage was a key advantage, says senior author Su-Chun Zhang, a professor of neuroscience and neurology. "IPSC cells can generate any cell type, which could be a problem for cell-based therapy to repair damage due to disease or injury in the nervous system."
In ...
Gene variant appears to predict weight loss after gastric bypass
2013-05-02
Massachusetts General Hospital (MGH) researchers have identified a gene variant that helps predict how much weight an individual will lose after gastric bypass surgery, a finding with the potential both to guide treatment planning and to facilitate the development of new therapeutic approaches to treating obesity and related conditions like diabetes. The report receiving advance online publication in The American Journal of Human Genetics is the first to identify genetic predictors of weight loss after bariatric surgery.
"We know now that bypass surgery works not by ...
Study confirms everolimus can overcome trastuzumab resistance in HER-2 positive early breast cancer
2013-05-02
Lugano-CH, Brussels-BE, 2 May 2013 -- A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast cancers can develop to trastuzumab has left researchers contemplating a puzzle.
The study showed a statistically non-significant benefit in clinical response rates for some patients with early breast cancer when everolimus was added to treatment with trastuzumab. Yet the results suggest this benefit is achieved independently of the molecular pathways researchers expected would be involved.
Prof Mario Campone, Principal Investigator ...
Gene expression test distinguishes btw breast cancer patients at high & low risk of late recurrence
2013-05-02
Lugano-CH, Brussels-BE, 2 May 2013 -- A test that measures the expression levels of 58 genes in oestrogen receptor-positive breast cancers can effectively differentiate between patients who are at higher and lower risk for having their cancer recur elsewhere in the body more than five years after diagnosis, researchers report.
The new findings show that better individual risk prediction for women with these cancers is getting nearer, says study author Prof Michael Gnant from the Medical University of Vienna, Austria.
Prof Gnant reported the findings at the 5th IMPAKT ...
Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer
2013-05-02
Lugano-CH, Brussels-BE, 2 May 2013 -- A new analysis has provided a comprehensive comparison of scores designed to predict which women with oestrogen-receptor positive breast cancer are at high risk of recurrence beyond five years after diagnosis, and may benefit from prolonged endocrine treatment.
The promising new findings will likely benefit the many women with oestrogen-receptor positive breast cancer whose cancer recurs more than five years after diagnosis, researchers told the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
The IMPAKT meeting presents ...
Study reveals magnitude of variation in gene expression measurements within breast cancers
2013-05-02
Lugano-CH, Brussels- BE, 2 May 2013 -- An important new study has revealed the clearest picture yet of precisely how much measurement variation influences gene expression profiles of breast cancer.
The results show, for the first time, which gene expression measurements may benefit from pooling of biopsies from a single tumour, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
These findings represent an important step toward allowing doctors to more precisely tailor an individual's treatment to a detailed analysis of their tumour's gene ...
Study opens new prospects for developing new targeted therapies for breast cancer
2013-05-02
Lugano-CH, Brussels-BE, 2 May 2013 -- A study led by prominent breast cancer experts from Europe and the US has revealed a number of potentially important prospects for targeted therapies, and brings opportunities of truly personalised therapy for breast cancer a step closer, researchers said at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.
The IMPAKT meeting presents cutting edge, 'translational' breast cancer research that is beginning to have an impact for patients.
This current study was led by Dr Martine Piccart, Director of Medicine at the Jules ...
Breast cancer heterogeneity no barrier to predictive testing, study shows
2013-05-02
Lugano-CH, Brussels-BE, 2 May 2013 -- Breast cancers contain many different cell types with different patterns of gene expression, but a new study provides reassurance that this variability should not be a barrier to using gene expression tests to help tailor cancer treatments to individual patients.
The findings were reported at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium. The IMPAKT meeting presents cutting edge, 'translational' breast cancer research that is beginning to have an impact for patients.
In recent years it has become clear that breast ...
Primate hibernation more common than previously thought
2013-05-02
DURHAM, N.C. -- Until recently, the only primate known to hibernate as a survival strategy was a creature called the western fat-tailed dwarf lemur, a tropical tree-dweller from the African island of Madagascar.
But it turns out this hibernating lemur isn't alone. In a study appearing May 2 in the journal Scientific Reports, researchers report that two other little-known lemurs -- Crossley's dwarf lemur and Sibree's dwarf lemur -- burrow into the soft, spongy rainforest floor in the eastern part of Madagascar, curl up and spend the next three to seven months snoozing ...
Duke researchers identify gene mutations associated with nearsightedness
2013-05-02
DURHAM, N.C. -- People have long taken for granted that glasses and contact lenses improve vision for nearsightedness, but the genetic factors behind the common condition have remained blurry. Now researchers at Duke Medicine are closer to clearing this up.
Mutations in a gene that helps regulate copper and oxygen levels in eye tissue are associated with a severe form of nearsightedness, according to a study published in the American Journal of Human Genetics on May 2, 2013.
Nearsightedness – also known as myopia – is the most common human eye disease in the world. ...